88149-49-9Relevant articles and documents
COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY
-
Page/Page column 297-298, (2020/06/10)
In one aspect, compounds of Formula A, or a pharmaceutically acceptable salt thereof, are featured (Formula A) or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein.
Preparation method of thifluzamide key intermediate, namely 2,6-dibromo-4-(trifluoromethoxy)aniline
-
Paragraph 0022-0033, (2017/08/29)
The invention discloses a preparation method of a thifluzamide key intermediate, namely 2,6-dibromo-4-(trifluoromethoxy)aniline. The method comprises the following operating steps: (1) adding water into a reaction bottle, dropwise adding concentrated sulf